肿瘤分析市场规模、份额、趋势分析报告：按技术、製程、应用、地区、细分市场预测，2025-2030 年

Tumor Profiling Market Size, Share & Trends Analysis Report By Technique (Genomics, Proteomics), By Technology, By Application (Personalized Cancer Medicine), By Region, And Segment Forecasts, 2025 - 2030

出版日期: 2025年03月03日 | 出版商:

Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

简介目录图表

肿瘤分析市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，全球肿瘤分析市场规模预计到2030年将达到217亿美元，2025年至2030年期间的复合年增长率为10.4%。

体学科学在癌症检测中的应用日益广泛，预计将影响市场成长。

生物技术的进步使得人们能够深入了解新陈代谢和基因表现。这些正在加速代谢体学和表观遗传学等先进技术在癌症筛检和检测中的应用。因此，随着下游应用的扩展，癌症肿瘤分析（CTP）技术的需求预计将出现良好的成长。

癌症肿瘤分析是一种潜在的程序，可以检测癌症并进一步研究以确定肿瘤阶段、代谢和形态的变化。这有助于常规诊断和治疗决策。肿瘤分析对于根据疾病严重程度及其个体基因组图谱开发针对特定个体的治疗方法具有重要意义。

NGS 和原位杂交等增强检测和定序技术将有助于加速癌症肿瘤分析过程，预计在未来几年将获得显着发展。如此高的采用率归因于以最少的资源和更高的准确度获得结果的速度加快。

肿瘤分析市场报告重点

个人化癌症医疗有望成为采用CTP最具优势的应用领域。
由于癌细胞基因组学、表观基因和代谢组学分析得出的功能资讯的应用不同且相互依赖，这些技术领域预计将相互协同发展，并在预测期内呈现丰厚的成长。
由于主要经济体的各种发展以及新兴经济体主要企业的日益关注，预计亚太地区将在未来十年实现显着增长。

2024 年及 2030 年区域市场占有率分析
区域市场仪表板
2018年至2030年市场规模与预测趋势分析：
北美洲
- 2018-2030年各国情况
- 美国
- 加拿大
- 墨西哥
欧洲
- 2018-2030年各国情况
- 英国
- 德国
- 法国
- 义大利
- 西班牙
- 挪威
- 丹麦
- 瑞典
亚太地区
- 2018-2030年各国情况
- 日本
- 中国
- 印度
- 韩国
- 澳洲
- 泰国
拉丁美洲
- 2018-2030年各国情况
- 巴西
- 阿根廷
中东和非洲
- 2018-2030年各国情况
- 南非
- 沙乌地阿拉伯
- 阿拉伯聯合大公国
- 科威特

第八章竞争格局

参与企业概况
企业市场分析
公司分类
战略地图
公司简介/列表
- Illumina Inc.
- Qiagen NV
- Exact Sciences Corporation
- NeoGenomics Laboratories
- Oxford Gene Technology IP Limited
- Bruker Spatial Biology, Inc.
- GenomeDX
- Guardant Health
- Foundation Medicine, Inc.

简介目录图表

Product Code: GVR-2-68038-625-7

Tumor Profiling Market Growth & Trends:

The global tumor profiling market size is expected to reach USD 21.7 billion by 2030, expanding at a CAGR of 10.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising research in the application of omics sciences in cancer detection is anticipated to influence market growth.

Technological advances in biotechnology have allowed for deeper insights into metabolism and gene expression. These have accelerated the application of advanced techniques such as metabolomics and epigenetics in cancer screening and detection. Thus, demand for cancer tumor/profiling (CTP) techniques is anticipated to witness lucrative growth with the expansion of downstream applications.

Cancer tumor profiling is a potential procedure through which cancer can be detected and studied further to identify the stage, metabolism, and changes in morphology of the tumor. This aids in routine diagnostics as well as therapeutic decision-making. Tumor profiling has significant importance in developing therapies aimed at a specific individual, based on the severity of ailment and genomic build up of the individual.

Enhanced detection and sequencing techniques such as NGS and in-situ hybridization can help speed up the cancer tumor profiling process and are estimated to gain much traction over the coming years. Their high adoption is attributive to accelerated speed in gaining results with minimum resources and greater accuracy.

Tumor Profiling Market Report Highlights:

Personalized cancer medicine is expected to be the most lucrative application segment for CTP adoption.
Owing to difference in usage of and interdependency of functional information from genomic, epigenomic, and metabolomic analysis of cancer cells, it can be expected that these technology segments will grow in tandem with each other and exhibit lucrative growth over the forecast years
Asia Pacific is projected to witness substantial growth over the next decade owing to various developments across major economies, with increased focus of dominant players in emerging economies as well

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Technique
- 1.2.2. Technology
- 1.2.3. Application
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
1.6. Information Analysis
- 1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
- 1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Tumor Profiling Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
  - 3.3.1.1. Supplier Power
  - 3.3.1.2. Buyer Power
  - 3.3.1.3. Substitution Threat
  - 3.3.1.4. Threat of New Entrants
  - 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTLE Analysis

Chapter 4. Tumor Profiling Market: Technique Business Analysis

4.1. Technique Market Share, 2024 & 2030
4.2. Technique Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Technique, 2018 to 2030 (USD Million)
4.4. Genomics
- 4.4.1. Genomics Market, 2018 - 2030 (USD Million)
4.5. Proteomics
- 4.5.1. Proteomics Market, 2018 - 2030 (USD Million)
4.6. Metabolomics
- 4.6.1. Metabolomics Market, 2018 - 2030 (USD Million)
4.7. Epigenetics
- 4.7.1. Epigenetics Market, 2018 - 2030 (USD Million)

Chapter 5. Tumor Profiling Market: Technology Business Analysis

5.1. Technology Market Share, 2024 & 2030
5.2. Technology Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Million)
5.4. Sequencing Techniques
- 5.4.1. Sequencing Techniques Market, 2018 - 2030 (USD Million)
5.5. In Situ Hybridization
- 5.5.1. In Situ Hybridization Market, 2018 - 2030 (USD Million)
5.6. Immunohistochemistry
- 5.6.1. Immunohistochemistry Market, 2018 - 2030 (USD Million)
5.7. qPCR
- 5.7.1. qPCR Market, 2018 - 2030 (USD Million)
5.8. Microarray
- 5.8.1. Microarray Market, 2018 - 2030 (USD Million)

Chapter 6. Tumor Profiling Market: Application Business Analysis

6.1. Application Market Share, 2024 & 2030
6.2. Application Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
6.4. Personalized Cancer Medicine
- 6.4.1. Personalized Cancer Medicine Market, 2018 - 2030 (USD Million)
6.5. Oncological Diagnostics
- 6.5.1. Oncological Diagnostics Market, 2018 - 2030 (USD Million)
6.6. Research
- 6.6.1. Research Market, 2018 - 2030 (USD Million)

Chapter 7. Tumor Profiling Market: Regional Estimates & Trend Analysis

7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
7.4. North America
- 7.4.1. North America Tumor Profiling Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 7.4.2. U.S.
  - 7.4.2.1. Key Country Dynamics
  - 7.4.2.2. Regulatory Framework
  - 7.4.2.3. Competitive Insights
  - 7.4.2.4. U.S. Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.4.3. Canada
  - 7.4.3.1. Key Country Dynamics
  - 7.4.3.2. Regulatory Framework
  - 7.4.3.3. Competitive Insights
  - 7.4.3.4. Canada Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.4.4. Mexico
  - 7.4.4.1. Key Country Dynamics
  - 7.4.4.2. Regulatory Framework
  - 7.4.4.3. Competitive Insights
  - 7.4.4.4. Mexico Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5. Europe
- 7.5.1. Europe Tumor Profiling Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 7.5.2. UK
  - 7.5.2.1. Key Country Dynamics
  - 7.5.2.2. Regulatory Framework
  - 7.5.2.3. Competitive Insights
  - 7.5.2.4. UK Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Germany
  - 7.5.3.1. Key Country Dynamics
  - 7.5.3.2. Regulatory Framework
  - 7.5.3.3. Competitive Insights
  - 7.5.3.4. Germany Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.4. France
  - 7.5.4.1. Key Country Dynamics
  - 7.5.4.2. Regulatory Framework
  - 7.5.4.3. Competitive Insights
  - 7.5.4.4. France Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.5. Italy
  - 7.5.5.1. Key Country Dynamics
  - 7.5.5.2. Regulatory Framework
  - 7.5.5.3. Competitive Insights
  - 7.5.5.4. Italy Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.6. Spain
  - 7.5.6.1. Key Country Dynamics
  - 7.5.6.2. Regulatory Framework
  - 7.5.6.3. Competitive Insights
  - 7.5.6.4. Spain Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.7. Norway
  - 7.5.7.1. Key Country Dynamics
  - 7.5.7.2. Regulatory Framework
  - 7.5.7.3. Competitive Insights
  - 7.5.7.4. Norway Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.8. Denmark
  - 7.5.8.1. Key Country Dynamics
  - 7.5.8.2. Regulatory Framework
  - 7.5.8.3. Competitive Insights
  - 7.5.8.4. Denmark Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.9. Sweden
  - 7.5.9.1. Key Country Dynamics
  - 7.5.9.2. Regulatory Framework
  - 7.5.9.3. Competitive Insights
  - 7.5.9.4. Sweden Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6. Asia Pacific
- 7.6.1. Asia Pacific Tumor Profiling Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 7.6.2. Japan
  - 7.6.2.1. Key Country Dynamics
  - 7.6.2.2. Regulatory Framework
  - 7.6.2.3. Competitive Insights
  - 7.6.2.4. Japan Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. China
  - 7.6.3.1. Key Country Dynamics
  - 7.6.3.2. Regulatory Framework
  - 7.6.3.3. Competitive Insights
  - 7.6.3.4. China Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.4. India
  - 7.6.4.1. Key Country Dynamics
  - 7.6.4.2. Regulatory Framework
  - 7.6.4.3. Competitive Insights
  - 7.6.4.4. India Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.5. South Korea
  - 7.6.5.1. Key Country Dynamics
  - 7.6.5.2. Regulatory Framework
  - 7.6.5.3. Competitive Insights
  - 7.6.5.4. South Korea Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.6. Australia
  - 7.6.6.1. Key Country Dynamics
  - 7.6.6.2. Regulatory Framework
  - 7.6.6.3. Competitive Insights
  - 7.6.6.4. Australia Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.7. Thailand
  - 7.6.7.1. Key Country Dynamics
  - 7.6.7.2. Regulatory Framework
  - 7.6.7.3. Competitive Insights
  - 7.6.7.4. Thailand Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.7. Latin America
- 7.7.1. Latin America Tumor Profiling Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 7.7.2. Brazil
  - 7.7.2.1. Key Country Dynamics
  - 7.7.2.2. Regulatory Framework
  - 7.7.2.3. Competitive Insights
  - 7.7.2.4. Brazil Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.7.3. Argentina
  - 7.7.3.1. Key Country Dynamics
  - 7.7.3.2. Regulatory Framework
  - 7.7.3.3. Competitive Insights
  - 7.7.3.4. Argentina Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.8. MEA
- 7.8.1. MEA Tumor Profiling Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 7.8.2. South Africa
  - 7.8.2.1. Key Country Dynamics
  - 7.8.2.2. Regulatory Framework
  - 7.8.2.3. Competitive Insights
  - 7.8.2.4. South Africa Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.8.3. Saudi Arabia
  - 7.8.3.1. Key Country Dynamics
  - 7.8.3.2. Regulatory Framework
  - 7.8.3.3. Competitive Insights
  - 7.8.3.4. Saudi Arabia Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.8.4. UAE
  - 7.8.4.1. Key Country Dynamics
  - 7.8.4.2. Regulatory Framework
  - 7.8.4.3. Competitive Insights
  - 7.8.4.4. UAE Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.8.5. Kuwait
  - 7.8.5.1. Key Country Dynamics
  - 7.8.5.2. Regulatory Framework
  - 7.8.5.3. Competitive Insights
  - 7.8.5.4. Kuwait Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
- 8.5.1. Illumina Inc.
  - 8.5.1.1. Overview
  - 8.5.1.2. Financial Performance
  - 8.5.1.3. Product Benchmarking
  - 8.5.1.4. Strategic Initiatives
- 8.5.2. Qiagen N.V.
  - 8.5.2.1. Overview
  - 8.5.2.2. Financial Performance
  - 8.5.2.3. Product Benchmarking
  - 8.5.2.4. Strategic Initiatives
- 8.5.3. Exact Sciences Corporation
  - 8.5.3.1. Overview
  - 8.5.3.2. Financial Performance
  - 8.5.3.3. Product Benchmarking
  - 8.5.3.4. Strategic Initiatives
- 8.5.4. NeoGenomics Laboratories
  - 8.5.4.1. Overview
  - 8.5.4.2. Financial Performance
  - 8.5.4.3. Product Benchmarking
  - 8.5.4.4. Strategic Initiatives
- 8.5.5. Oxford Gene Technology IP Limited
  - 8.5.5.1. Overview
  - 8.5.5.2. Financial Performance
  - 8.5.5.3. Product Benchmarking
  - 8.5.5.4. Strategic Initiatives
- 8.5.6. Bruker Spatial Biology, Inc.
  - 8.5.6.1. Overview
  - 8.5.6.2. Financial Performance
  - 8.5.6.3. Product Benchmarking
  - 8.5.6.4. Strategic Initiatives
- 8.5.7. GenomeDX
  - 8.5.7.1. Overview
  - 8.5.7.2. Financial Performance
  - 8.5.7.3. Product Benchmarking
  - 8.5.7.4. Strategic Initiatives
- 8.5.8. Guardant Health
  - 8.5.8.1. Overview
  - 8.5.8.2. Financial Performance
  - 8.5.8.3. Product Benchmarking
  - 8.5.8.4. Strategic Initiatives
- 8.5.9. Foundation Medicine, Inc.
  - 8.5.9.1. Overview
  - 8.5.9.2. Financial Performance
  - 8.5.9.3. Product Benchmarking
  - 8.5.9.4. Strategic Initiatives

简介目录图表

List of Tables

Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. Global tumor profiling market, by region, 2018 - 2030 (USD Million)
Table 4. Global tumor profiling market, by technique, 2018 - 2030 (USD Million)
Table 5. Global tumor profiling market, by technology, 2018 - 2030 (USD Million)
Table 6. Global tumor profiling market, by application, 2018 - 2030 (USD Million)
Table 7. North America tumor profiling market, by country, 2018 - 2030 (USD Million)
Table 8. North America tumor profiling market, by technique, 2018 - 2030 (USD Million)
Table 9. North America tumor profiling market, by technology, 2018 - 2030 (USD Million)
Table 10. North America tumor profiling market, by application, 2018 - 2030 (USD Million)
Table 11. U.S. tumor profiling market, by technique, 2018 - 2030 (USD Million)
Table 12. U.S. tumor profiling market, by technology, 2018 - 2030 (USD Million)
Table 13. U.S. Tumor Profiling market, by application, 2018 - 2030 (USD Million)
Table 14. Canada tumor profiling market, by technique, 2018 - 2030 (USD Million)
Table 15. Canada tumor profiling market, by technology, 2018 - 2030 (USD Million)
Table 16. Canada tumor profiling market, by application, 2018 - 2030 (USD Million)
Table 17. Mexico tumor profiling market, by technique, 2018 - 2030 (USD Million)
Table 18. Mexico tumor profiling market, by technology, 2018 - 2030 (USD Million)
Table 19. Mexico tumor profiling market, by application, 2018 - 2030 (USD Million)
Table 20. Europe tumor profiling market, by country, 2018 - 2030 (USD Million)
Table 21. Europe tumor profiling market, by technique, 2018 - 2030 (USD Million)
Table 22. Europe tumor profiling market, by technology, 2018 - 2030 (USD Million)
Table 23. Europe tumor profiling market, by application, 2018 - 2030 (USD Million)
Table 24. UK tumor profiling market, by technique, 2018 - 2030 (USD Million)
Table 25. UK tumor profiling market, by technology, 2018 - 2030 (USD Million)
Table 26. UK tumor profiling market, by application, 2018 - 2030 (USD Million)
Table 27. Germany tumor profiling market, by technique, 2018 - 2030 (USD Million)
Table 28. Germany tumor profiling market, by technology, 2018 - 2030 (USD Million)
Table 29. Germany tumor profiling market, by application, 2018 - 2030 (USD Million)
Table 30. France tumor profiling market, by technique, 2018 - 2030 (USD Million)
Table 31. France tumor profiling market, by technology, 2018 - 2030 (USD Million)
Table 32. France tumor profiling market, by application, 2018 - 2030 (USD Million)
Table 33. Italy tumor profiling market, by technique, 2018 - 2030 (USD Million)
Table 34. Italy tumor profiling market, by technology, 2018 - 2030 (USD Million)
Table 35. Italy tumor profiling market, by application, 2018 - 2030 (USD Million)
Table 36. Spain tumor profiling market, by technique, 2018 - 2030 (USD Million)
Table 37. Spain tumor profiling market, by technology, 2018 - 2030 (USD Million)
Table 38. Spain tumor profiling market, by application, 2018 - 2030 (USD Million)
Table 39. Norway tumor profiling market, by technique, 2018 - 2030 (USD Million)
Table 40. Norway tumor profiling market, by technology, 2018 - 2030 (USD Million)
Table 41. Norway tumor profiling market, by application, 2018 - 2030 (USD Million)
Table 42. Denmark tumor profiling market, by technique, 2018 - 2030 (USD Million)
Table 43. Denmark tumor profiling market, by technology, 2018 - 2030 (USD Million)
Table 44. Denmark tumor profiling market, by application, 2018 - 2030 (USD Million)
Table 45. Sweden tumor profiling market, by technique, 2018 - 2030 (USD Million)
Table 46. Sweden tumor profiling market, by technology, 2018 - 2030 (USD Million)
Table 47. Sweden tumor profiling market, by application, 2018 - 2030 (USD Million)
Table 48. Asia Pacific tumor profiling market, by country, 2018 - 2030 (USD Million)
Table 49. Asia Pacific tumor profiling market, by technique, 2018 - 2030 (USD Million)
Table 50. Asia Pacific tumor profiling market, by technology, 2018 - 2030 (USD Million)
Table 51. Asia Pacific tumor profiling market, by application, 2018 - 2030 (USD Million)
Table 52. Japan tumor profiling market, by technique, 2018 - 2030 (USD Million)
Table 53. Japan tumor profiling market, by technology, 2018 - 2030 (USD Million)
Table 54. Japan tumor profiling market, by application, 2018 - 2030 (USD Million)
Table 55. China tumor profiling market, by technique, 2018 - 2030 (USD Million)
Table 56. China tumor profiling market, by technology, 2018 - 2030 (USD Million)
Table 57. China tumor profiling market, by application, 2018 - 2030 (USD Million)
Table 58. India tumor profiling market, by technique, 2018 - 2030 (USD Million)
Table 59. India tumor profiling market, by technology, 2018 - 2030 (USD Million)
Table 60. India tumor profiling market, by application, 2018 - 2030 (USD Million)
Table 61. Australia tumor profiling market, by technique, 2018 - 2030 (USD Million)
Table 62. Australia tumor profiling market, by technology, 2018 - 2030 (USD Million)
Table 63. Australia tumor profiling market, by application, 2018 - 2030 (USD Million)
Table 64. South Korea tumor profiling market, by technique, 2018 - 2030 (USD Million)
Table 65. South Korea tumor profiling market, by technology, 2018 - 2030 (USD Million)
Table 66. South Korea tumor profiling market, by application, 2018 - 2030 (USD Million)
Table 67. Thailand tumor profiling market, by technique, 2018 - 2030 (USD Million)
Table 68. Thailand tumor profiling market, by technology, 2018 - 2030 (USD Million)
Table 69. Thailand tumor profiling market, by application, 2018 - 2030 (USD Million)
Table 70. Latin America tumor profiling market, by country, 2018 - 2030 (USD Million)
Table 71. Latin America tumor profiling market, by technique, 2018 - 2030 (USD Million)
Table 72. Latin America tumor profiling market, by technology, 2018 - 2030 (USD Million)
Table 73. Latin America tumor profiling market, by application, 2018 - 2030 (USD Million)
Table 74. Brazil tumor profiling market, by technique, 2018 - 2030 (USD Million)
Table 75. Brazil tumor profiling market, by technology, 2018 - 2030 (USD Million)
Table 76. Brazil tumor profiling market, by application, 2018 - 2030 (USD Million)
Table 77. Argentina tumor profiling market, by technique, 2018 - 2030 (USD Million)
Table 78. Argentina tumor profiling market, by technology, 2018 - 2030 (USD Million)
Table 79. Argentina tumor profiling market, by application, 2018 - 2030 (USD Million)
Table 80. Middle East & Africa tumor profiling market, by country, 2018 - 2030 (USD Million)
Table 81. Middle East & Africa tumor profiling market, by technique, 2018 - 2030 (USD Million)
Table 82. Middle East & Africa tumor profiling market, by technology, 2018 - 2030 (USD Million)
Table 83. Middle East & Africa tumor profiling market, by application, 2018 - 2030 (USD Million)
Table 84. South Africa tumor profiling market, by technique, 2018 - 2030 (USD Million)
Table 85. South Africa tumor profiling market, by technology, 2018 - 2030 (USD Million)
Table 86. South Africa tumor profiling market, by application, 2018 - 2030 (USD Million)
Table 87. Saudi Arabia tumor profiling market, by technique, 2018 - 2030 (USD Million)
Table 88. Saudi Arabia tumor profiling market, by technology, 2018 - 2030 (USD Million)
Table 89. Saudi Arabia tumor profiling market, by application, 2018 - 2030 (USD Million)
Table 90. UAE tumor profiling market, by technique, 2018 - 2030 (USD Million)
Table 91. UAE tumor profiling market, by technology, 2018 - 2030 (USD Million)
Table 92. UAE tumor profiling market, by application, 2018 - 2030 (USD Million)
Table 93. Kuwait tumor profiling market, by technique, 2018 - 2030 (USD Million)
Table 94. Kuwait tumor profiling market, by technology, 2018 - 2030 (USD Million)
Table 95. Kuwait tumor profiling market, by application, 2018 - 2030 (USD Million)